RxDoctor Payments Data

Rebecca McLaughlin

Optometrist · Auburn, MANPI 1639564180

Payments from drug & device makers

$948in general payments, 2019–2025

Across 35 payments — averaging $27.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tarsus Pharmaceuticals, Inc.$221
  • Alcon$156
  • AbbVie$144
  • Sun Pharmaceutical Industries Inc.$89
  • Johnson & Johnson Vision Care, Inc.$82
  • Oyster Point Pharma, Inc.$53
  • plus $204 from 7 others

What the payments were for

  • Food & beverage$948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$948 in reported general payments places this provider in the 65th percentile of 1,084 optometrist providers in Massachusetts.

See all optometrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$58,433
Medicare patients
302
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost51$724

Paid to pharmacies, not to this prescriber.

Other optometrist in Auburn

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →